Shape Memory Therapeutics, Inc.
Shape Memory Therapeutics (SMT) is a medical device company founded to commercialize innovative medical devices based on Shape Memory Polymer (SMP) materials developed at Lawrence Livermore National Laboratory and Texas A&M University. SMT will leverage the unique properties of SMPs – high expansion capability and a low expansion force – for minimally invasive (endovascular) applications. The company will target the cerebral aneurysm market. SMT expects to capture an estimated 10% of the $ 1.2 billion worldwide endovascular cerebral aneurysm market.